Cortisol Testing In Clinical Practice

Last updated: October 4, 2026 - Reviewed by Verdant Wellness Editorial Team

A comprehensive, evidence-based guide to understanding cortisol clinical testing methods, interpretation, and diagnostic applications

Table of Contents

• What Is Cortisol and Why Does Clinical Testing Matter?
• Understanding the Cortisol Rhythm: Timing Is Everything
• Cortisol Test Types: A Complete Overview
• Cortisol Blood Test Clinical Applications
• 24-Hour Urine Cortisol: When and Why
• Salivary Cortisol Testing: The Modern Standard
• ACTH Stimulation Test Cortisol: Diagnosing Adrenal Insufficiency
• Low Dose Dexamethasone Cortisol Suppression Testing
• Cushing's Syndrome Cortisol Test: Diagnostic Protocols
• Clinical Cortisol Evaluation: Interpreting Results
• Total Cortisol vs. Free Cortisol: Which Is Clinically Relevant?
• Cortisol Testing Methods Clinical Comparison: Immunoassay vs. LC-MS/MS
• Factors That Affect Cortisol Test Results
• At-Home Cortisol Tests vs. Laboratory Testing: An Honest Comparison
• Normal vs. Abnormal Cortisol Levels: A Clinical Reference
• Frequently Asked Questions
• Summary and Clinical Takeaways

Introduction

Cortisol is one of the most clinically significant hormones in human physiology. Produced by the adrenal cortex in response to adrenocorticotropic hormone (ACTH), it regulates metabolism, immune function, blood pressure, and the body's stress response. When cortisol levels fall outside their normal range — whether chronically elevated, deficient, or dysregulated in their diurnal pattern — the consequences for patient health can be severe and wide-ranging.

Yet despite its importance, cortisol testing in clinical practice remains a topic fraught with complexity. Clinicians must navigate multiple testing modalities, interpret results within the context of timing and patient variables, distinguish between total and free cortisol, and select the most analytically reliable method for their specific diagnostic question. For patients, the experience of being tested can be confusing: why is blood drawn in the morning? Why might a urine collection be required? Why do some labs use saliva?

This guide is designed to answer all of those questions with clarity and clinical precision. Whether you are a primary care physician ordering your first cortisol workup, an endocrinologist refining your diagnostic approach, or a patient trying to understand what your results mean, this comprehensive resource will walk you through every dimension of cortisol clinical testing — from the biology of the hormone itself to the cutting-edge analytical methods now reshaping the field.

★★★★★ 4.8 · 1,247 reviews

Feel Calm By Bedtime. Focused By Morning.

Adaptogen-based formula. Third-party tested. Made in an FDA-registered facility. Backed by a 60-day money-back guarantee.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

What Is Cortisol and Why Does Clinical Testing Matter?

Cortisol is a glucocorticoid steroid hormone synthesized from cholesterol in the zona fasciculata of the adrenal cortex. Its release is governed by the hypothalamic-pituitary-adrenal (HPA) axis: the hypothalamus secretes corticotropin-releasing hormone (CRH), which stimulates the anterior pituitary to release ACTH, which in turn drives the adrenal glands to produce and secrete cortisol. This cascade is subject to negative feedback — rising cortisol suppresses both CRH and ACTH — creating a tightly regulated system under normal physiological conditions.

Physiological Roles of Cortisol

Cortisol serves multiple essential functions:

• Metabolic regulation: It promotes gluconeogenesis, increases blood glucose availability, and mobilizes fatty acids and amino acids
• Anti-inflammatory and immunosuppressive effects: Cortisol downregulates the inflammatory response, making synthetic analogs like prednisone valuable therapeutic agents
• Cardiovascular function: It maintains vascular tone and blood pressure sensitivity to catecholamines
• Stress adaptation: During acute physical or psychological stress, cortisol levels surge to support the "fight-or-flight" response
• Circadian regulation: Cortisol peaks in the early morning (typically within 30–60 minutes of waking) and falls to its nadir in the late evening, influencing sleep-wake cycles

Why Clinical Cortisol Testing Is Essential

The clinical consequences of cortisol dysregulation span a broad spectrum. At the high end, Cushing's syndrome — caused by chronically elevated cortisol — leads to central obesity, hypertension, diabetes, osteoporosis, and psychiatric disturbance. At the low end, adrenal insufficiency (including Addison's disease) results in fatigue, hypotension, hyponatremia, hyperkalemia, and potentially life-threatening adrenal crisis.

Between these poles exists a spectrum of HPA axis dysfunction that may contribute to metabolic syndrome, mood disorders, sleep disturbance, and autoimmune conditions. Accurate cortisol clinical testing is therefore not merely a specialty concern — it is increasingly relevant to primary care, psychiatry, endocrinology, and critical care medicine.

The challenge is that no single cortisol test answers every clinical question. The choice of test — blood, urine, saliva; stimulated or suppressed; morning or nighttime — depends entirely on the diagnostic hypothesis being pursued. This guide will help clinicians and patients understand exactly which test to use, when, and why.

Understanding the Cortisol Rhythm: Timing Is Everything

Before exploring specific cortisol test types, it is essential to understand the diurnal (circadian) rhythm of cortisol secretion, because this rhythm defines the reference ranges, optimal collection times, and interpretive frameworks for virtually every cortisol assay in clinical use.

The Cortisol Awakening Response and Diurnal Pattern

Cortisol follows a well-characterized 24-hour secretory pattern:

• Peak secretion: Approximately 30–45 minutes after waking, typically between 6:00 and 9:00 AM in individuals with conventional sleep schedules. This is often called the cortisol awakening response (CAR) and represents a 50–100% surge above pre-waking levels.
• Gradual decline: Throughout the morning and afternoon, cortisol levels fall progressively
• Nadir: In the late evening (approximately 11:00 PM to midnight), cortisol reaches its lowest daily concentration — a phase critical to several diagnostic tests
• Nocturnal trough: Maintained through most of the sleep period, with the rise beginning in the early hours before waking

This rhythm is driven by the suprachiasmatic nucleus of the hypothalamus and is synchronized to the light-dark cycle. It can be disrupted by shift work, jet lag, sleep deprivation, chronic stress, alcohol use, depression, and various medications.

Clinical Implications of Timing

The timing of cortisol testing has profound implications for both clinical accuracy and diagnostic interpretation:

1. Morning cortisol tests (drawn between 8:00 and 9:00 AM) reflect peak cortisol output and are used to screen for adrenal insufficiency. A low morning cortisol in this window is clinically significant.

1. Late-night cortisol tests (salivary samples collected at or after 11:00 PM) exploit the normal nadir to detect cortisol excess. In Cushing's syndrome, this nighttime nadir is abolished — cortisol remains elevated even at midnight.

1. 24-hour urine collections integrate total cortisol output across the full circadian cycle, smoothing out transient fluctuations.

1. Stimulation tests (ACTH stimulation) are time-anchored to maximize the measurable adrenal reserve response.

1. Suppression tests (dexamethasone) rely on the feedback mechanism of the HPA axis and are typically assessed via morning cortisol the day after dexamethasone administration.

Understanding this rhythm also explains why a "high" or "low" result must always be interpreted relative to the time of collection. A cortisol level of 15 μg/dL (414 nmol/L) might be reassuringly normal at 8:00 AM but alarmingly elevated at 11:00 PM.

Cortisol Test Types: A Complete Overview

Cortisol test types can be broadly categorized by specimen type, by whether they measure basal or dynamic (stimulated/suppressed) cortisol, and by the analytical method used. Each has distinct clinical applications, advantages, and limitations.

By Specimen Type

| Specimen | Primary Use | Key Advantage | Key Limitation | |---|---|---|---| | Serum/Plasma (Blood) | Morning cortisol, adrenal insufficiency screening | Widely available, well-validated reference ranges | Measures total cortisol; affected by CBG levels | | Salivary | Late-night cortisol, Cushing's screening, free cortisol monitoring | Measures free cortisol; non-invasive; captures diurnal pattern | Collection compliance; food/oral contamination risk | | 24-Hour Urine | Cushing's syndrome evaluation | Integrates total daily output | Cumbersome collection; multiple influencing variables | | Spot Urine | Emerging research; some point-of-care applications | Convenient | Not yet standardized for routine clinical use |

By Test Functionality

| Test Type | Clinical Purpose | |---|---| | Basal cortisol (blood or saliva) | Screening for excess or deficiency at a specific time point | | ACTH Stimulation Test | Assessing adrenal reserve; diagnosing adrenal insufficiency | | Low-Dose Dexamethasone Suppression Test (LDDST) | Screening for cortisol excess (Cushing's syndrome) | | High-Dose Dexamethasone Suppression Test (HDDST) | Differentiating Cushing's disease from ectopic ACTH | | 24-Hour UFC | Quantifying total daily cortisol production | | Late-Night Salivary Cortisol (LNSC) | Detecting loss of diurnal rhythm (Cushing's syndrome screening) | | CRH Stimulation Test | Differentiating pituitary vs. adrenal vs. ectopic Cushing's | | Insulin Tolerance Test (ITT) | Gold standard for hypothalamic-pituitary-adrenal axis integrity (high risk; specialist use only) |

By Analytical Method

• Immunoassay (radioimmunoassay [RIA], enzyme-linked immunosorbent assay [ELISA], automated chemiluminescent immunoassay [CLIA]): Widely used in routine clinical laboratories; fast and cost-effective but subject to cross-reactivity and inter-assay variability
• Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS): The current gold standard for specificity and sensitivity; increasingly available in reference laboratories
• High-Performance Liquid Chromatography (HPLC): An intermediate option with better specificity than immunoassay but less accessible than LC-MS/MS

This diversity of cortisol testing methods clinical settings offer reflects the breadth of diagnostic questions cortisol testing must answer. The following sections examine each major test type in detail.

Cortisol Blood Test Clinical Applications

The cortisol blood test clinical standard has been the serum or plasma cortisol drawn from a peripheral vein, most commonly measured as total cortisol. This is the test most physicians encounter first and the one patients most frequently receive in a general practice or hospital setting.

What a Cortisol Blood Test Measures

In the bloodstream, cortisol circulates in three forms:

1. Protein-bound cortisol (~90–95%): The majority is bound to corticosteroid-binding globulin (CBG, also called transcortin) and to a lesser extent albumin. This fraction is biologically inactive and unavailable to tissues.
2. Free cortisol (~5–10%): Unbound cortisol that is biologically active and available to enter cells and exert effects
3. Weakly albumin-bound cortisol: Loosely associated and considered partially available

Standard serum cortisol assays measure total cortisol — the sum of all three fractions. This is clinically useful in most circumstances but can be misleading when CBG levels are abnormal.

When CBG Distorts Total Cortisol Results

CBG is produced by the liver and its levels are influenced by:

• Pregnancy and estrogen therapy: Elevate CBG → artificially elevated total cortisol, may suggest false Cushing's
• Nephrotic syndrome, liver disease, hypothyroidism: Lower CBG → artificially depressed total cortisol, may suggest false adrenal insufficiency
• Critical illness: CBG levels fall dramatically, meaning total cortisol may underestimate functional free cortisol in ICU patients

In patients with CBG abnormalities, measuring free cortisol (either by equilibrium dialysis or salivary cortisol as a proxy) provides a more accurate clinical picture.

How Doctors Test Cortisol: The Standard Morning Draw

How doctors test cortisol using a blood draw follows a well-established protocol:

1. Patient preparation: The patient is typically asked to fast overnight or for at least 2–4 hours prior to collection (though some protocols allow water)
2. Timing: Blood is drawn between 8:00 and 9:00 AM to capture the morning peak. Collection after 9:00 AM may yield lower values that can be misinterpreted as pathological
3. Venipuncture: A standard venous blood draw; EDTA or heparin plasma tubes may be used depending on assay requirements
4. Laboratory processing: Serum or plasma is separated and analyzed by immunoassay or LC-MS/MS
5. Result reporting: Typically in ng/mL, μg/dL, or nmol/L depending on the laboratory

Reference Ranges for Serum Cortisol

According to available laboratory and clinical references, normal serum cortisol ranges are approximately:

• Morning (8:00–9:00 AM): 50–163 ng/mL (equivalent to approximately 138–450 nmol/L or 5–16 μg/dL)
• Afternoon (4:00 PM): Typically 40–60% lower than morning values
• Evening/Midnight: Typically <50 nmol/L (< ~4 μg/dL) in healthy individuals

Note: Reference ranges vary between laboratories and assay platforms. Always interpret results in context of the laboratory's own reference intervals.

Clinical Indications for a Cortisol Blood Test

• Screening for adrenal insufficiency (Addison's disease, secondary adrenal insufficiency)
• Evaluation of possible Cushing's syndrome (in combination with other tests)
• Monitoring cortisol replacement therapy in patients with adrenal insufficiency
• Assessment of critically ill patients with suspected relative adrenal insufficiency
• Evaluation of pituitary function as part of a full hormonal panel

★★★★★ 4.8 · 1,247 reviews

The Adaptogens Your Nervous System Has Been Missing.

Ashwagandha, rhodiola, and phosphatidylserine — clinically-studied ingredients that support healthy cortisol rhythms.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

24-Hour Urine Cortisol: When and Why

The 24-hour urine cortisol test — also called urinary free cortisol (UFC) — measures the total amount of unbound (free) cortisol excreted in urine over a full 24-hour period. Unlike a single-point blood test, this test integrates cortisol output across the entire diurnal cycle, capturing total daily production and eliminating the influence of transient stress, CBG levels, or the timing of a single sample.

Why Urine Cortisol Reflects Free Cortisol

The kidney filters cortisol from the bloodstream. Only free (unbound) cortisol passes through the glomerular filter into the urine, because protein-bound cortisol is too large to be filtered. Most of this filtered cortisol is metabolized in the tubules, but a small fraction — roughly 1–2% of total daily cortisol production — is excreted unchanged as free cortisol in the urine.

This makes UFC a direct measure of integrated free cortisol exposure over 24 hours, which is physiologically more relevant than total serum cortisol in many clinical contexts.

Clinical Indications

The 24-hour urine cortisol test is primarily used as one of the three first-line tests for Cushing's syndrome, alongside late-night salivary cortisol and the low-dose dexamethasone suppression test. It is recommended when:

• Clinical features suggest cortisol excess (central obesity, violaceous striae, easy bruising, proximal myopathy, hypertension, glucose intolerance)
• Screening is needed in patients who may have confounders that affect serum cortisol or DST results
• Confirmation of elevated cortisol in a patient with an equivocal initial screening result

Collection Protocol

Accurate 24-hour UFC results depend entirely on proper urine collection. Patient education is critical:

1. Begin at a specific time (e.g., 7:00 AM): The patient voids and discards the first morning urine, noting the start time
2. Collect all urine for 24 hours: All subsequent urine is collected in a large container (typically 2.5–3 L), usually kept refrigerated
3. Final collection: The last sample collected is the first morning void the following day at the same time as the start
4. Measure total volume: The laboratory needs the total urine volume to calculate total daily excretion
5. Submit the sample (or an aliquot) promptly for analysis

Common Sources of Error in 24-Hour UFC

• Incomplete collection: The most common and most significant error. Missing even one void significantly underestimates the true 24-hour output.
• Over-collection: Less common, but including extra voids inflates the result
• High fluid intake: Excess hydration (>5 L/day) can elevate UFC by dilution effects and increased glomerular filtration
• Medications: Carbamazepine, fenofibrate, and synthetic glucocorticoids can falsely elevate immunoassay-based UFC results
• Renal insufficiency: A creatinine clearance below 30 mL/min supports healthy cortisol filtration and can falsely lower UFC

Reference Ranges for 24-Hour UFC

Normal 24-hour urinary free cortisol values are generally:

• Adults: Approximately 10–100 μg/24 hours (27.6–276 nmol/24 hours) by immunoassay
• LC-MS/MS methods: May yield somewhat lower values; laboratory-specific reference ranges should be used

In Cushing's syndrome, UFC values are typically elevated, often more than four times the upper limit of normal in florid Cushing's. Values two to three times the upper limit may be seen in pseudo-Cushing's states and require careful clinical contextualization.

Limitations of 24-Hour UFC

• Cumbersome collection reduces patient compliance, particularly in elderly patients or those with mobility limitations
• Sensitivity is limited in mild or cyclical Cushing's syndrome, where cortisol excess may not be continuously elevated
• Multiple collections (at least two) are recommended to account for day-to-day variability
• Not useful for diagnosing adrenal insufficiency, where other tests are more appropriate

Salivary Cortisol Testing: The Modern Standard

Salivary cortisol testing has emerged as one of the most clinically valuable and analytically advantageous methods in the modern cortisol testing armamentarium. Its ability to measure free (unbound) cortisol non-invasively, at specific time points, and outside of the clinical setting has made it particularly important for Cushing's syndrome screening and for monitoring hydrocortisone replacement therapy.

Why Salivary Cortisol Matters

Salivary cortisol reflects unbound (free) serum cortisol because only free cortisol — the biologically active fraction — passes passively through the salivary gland acinar cells into saliva. Since CBG and albumin do not cross this barrier, salivary cortisol is essentially unaffected by changes in binding protein concentrations. This gives it a significant advantage over serum total cortisol in patients with CBG abnormalities.

According to clinical research, salivary cortisol has been widely adopted in clinical laboratories as a convenient alternative to serum for monitoring hydrocortisone replacement therapy, due both to its non-invasive collection and its direct reflection of free cortisol levels.

The Late-Night Salivary Cortisol (LNSC) Test

The most clinically important application of salivary cortisol is the late-night salivary cortisol (LNSC) test, which exploits the normal midnight nadir of cortisol to detect Cushing's syndrome.

Clinical performance of LNSC:

Research data demonstrates that LNSC is a recommended first-line screening test for Cushing's syndrome, with:

• Sensitivity: 100% (95% confidence interval: 62.9–100%)
• Specificity: >96% (95% confidence interval: 92.8–100%)
• Cutoff: >6.1 nM (approximately 2.2 ng/mL)

These are among the strongest diagnostic performance metrics of any cortisol assay currently available for Cushing's syndrome screening, placing LNSC at the forefront of the clinical cortisol evaluation toolkit.

Collection Protocol for Late-Night Salivary Cortisol

1. Timing: Saliva is collected at or after 11:00 PM (between 11 PM and midnight), when cortisol should be at its physiological nadir
2. Method: The patient uses a commercially available Salivette® device or similar passive drool method to collect saliva into a tube. Chewing a cotton swab for 1–2 minutes saturates it with saliva.
3. Pre-collection instructions:

- Do not eat, drink (other than water), or brush teeth for at least 30 minutes before collection - Avoid oral or topical glucocorticoids that might contaminate the sample - Avoid tobacco, alcohol, or vigorous exercise in the hour before collection

1. Storage: Samples are stable at room temperature for up to several days and may be mailed to a laboratory
2. Repeat collections: Given the circadian and day-to-day variability of late-night salivary cortisol, two separate midnight samples are typically required for diagnostic purposes

Advantages of Salivary Cortisol Over Blood Testing

| Feature | Serum Cortisol | Salivary Cortisol | |---|---|---| | Specimen type | Blood (venipuncture) | Saliva (non-invasive) | | Fraction measured | Total cortisol | Free cortisol only | | CBG influence | Yes (significant) | No | | Collection at home | No | Yes | | Captures nighttime nadir | Requires hospital/clinic | Yes (patient self-collects) | | Stress from sampling | Yes (venipuncture) | Minimal | | Diurnal profile feasibility | Difficult (multiple draws) | Easy (multiple collections) |

Normal Reference Range for Salivary Cortisol

According to available laboratory data, a normal salivary cortisol value is approximately 5.27 ng/mL as a reference point, though this varies by time of day. Late-night values should fall well below the diagnostic cutoff of >6.1 nM (approximately 2.2 ng/mL) in healthy individuals.

Morning salivary cortisol peaks (typically within 30 minutes of waking) are considerably higher. Reference ranges are method-dependent and platform-specific.

Limitations of Salivary Cortisol Testing

• Food and beverage contamination: Certain foods (grapefruit, licorice), blood in the mouth (gingivitis, recent dental work), and some medications can interfere with results
• Shift workers and night shift staff: The midnight nadir may be temporally shifted in individuals with non-conventional sleep-wake cycles — collection protocols should account for this
• Immunoassay cross-reactivity: Particularly problematic for salivary samples, where cortisone and exogenous steroids can falsely elevate results
• Collection compliance: Results depend on proper patient technique and timing

ACTH Stimulation Test Cortisol: Diagnosing Adrenal Insufficiency

The ACTH stimulation test cortisol measurement — also known as the cosyntropin stimulation test, Synacthen test, or tetracosactide test — is the single most important dynamic test for diagnosing adrenal insufficiency. By administering a synthetic form of ACTH (cosyntropin) and measuring the cortisol response, clinicians can directly assess whether the adrenal glands have the capacity to produce adequate cortisol when stimulated.

Physiological Basis

Under normal circumstances, ACTH from the anterior pituitary drives the adrenal cortex to produce cortisol. If the adrenal glands are damaged or atrophied (primary adrenal insufficiency) or have been suppressed by chronic exogenous glucocorticoid use (secondary adrenal insufficiency), they will fail to produce an adequate cortisol rise in response to ACTH stimulation.

Administering supraphysiological doses of exogenous ACTH bypasses the hypothalamic-pituitary axis and directly stimulates adrenal steroidogenesis. A blunted or absent cortisol rise indicates compromised adrenal reserve.

Standard High-Dose ACTH Stimulation Test Protocol

Cosyntropin dose: 250 mcg (standard/high-dose test)

Procedure:

1. Draw a baseline serum cortisol sample (time 0)
2. Administer 250 mcg of synthetic ACTH (cosyntropin) intravenously or intramuscularly
3. Draw serum cortisol at 30 minutes and 60 minutes post-injection
4. Measure cortisol in all three samples by serum immunoassay or LC-MS/MS

Interpretation (standard high-dose test):

• Normal (adequate) response: Peak cortisol ≥ 18 μg/dL (500 nmol/L) at 30 or 60 minutes
• Abnormal (insufficient) response: Peak cortisol < 18 μg/dL — consistent with adrenal insufficiency

Note: Some guidelines (including the Endocrine Society 2016 guidelines) accept a lower threshold of ≥ 18 μg/dL (approximately 500 nmol/L) for the cosyntropin test, though some centers use 550 nmol/L as their cutoff. Institutional thresholds vary, particularly with different assay platforms.

Low-Dose ACTH Stimulation Test

A 1 mcg (low-dose) cosyntropin test has been proposed as a more sensitive alternative for detecting partial adrenal insufficiency, particularly secondary adrenal insufficiency due to pituitary disease. Because the low dose is closer to physiological ACTH stimulation, it may unmask adrenal insufficiency that the high-dose test misses.

Key considerations:

• The 1 mcg test requires careful preparation because cosyntropin is not commercially available at this dose and must be diluted from the 250 mcg preparation
• It has greater risk of false-positive results
• Use is not universally standardized; the high-dose test remains preferred in most clinical guidelines for simplicity and reproducibility

Types of Adrenal Insufficiency and ACTH Test Responses

| Condition | Baseline Cortisol | Post-ACTH Response | Baseline ACTH Level | |---|---|---|---| | Primary AI (Addison's) | Low | Blunted or absent | Markedly elevated | | Secondary AI (pituitary) | Low to low-normal | Blunted (partial) | Low or inappropriately normal | | Tertiary AI (hypothalamic) | Low to low-normal | Blunted (partial) | Low or inappropriately normal | | Healthy individual | Normal | Strong rise ≥18 μg/dL | Normal |

Special Clinical Scenarios

Critical illness: The ACTH stimulation test in critically ill patients is controversial. Many intensivists have used a delta cortisol response of <9 μg/dL (250 nmol/L) to identify patients who might benefit from hydrocortisone supplementation, but this practice remains debated and is not recommended as standard diagnostic criteria outside of specific research protocols.

Glucocorticoid withdrawal: Patients who have been on chronic exogenous glucocorticoid therapy (≥5 mg prednisone/day for ≥1 month or equivalent) are at risk for HPA axis suppression. The ACTH stimulation test is the preferred method for assessing recovery of adrenal function before tapering exogenous steroids.

Timing of the test: The ACTH stimulation test can be performed at any time of day, as the adrenal glands' capacity to respond to maximal ACTH stimulation does not depend on the time of collection. However, many centers perform it in the morning as part of standard endocrine protocols.

Low Dose Dexamethasone Cortisol Suppression Testing

The low dose dexamethasone cortisol suppression test (LDDST) is a cornerstone diagnostic tool for evaluating suspected cortisol excess (Cushing's syndrome). By administering a small dose of the synthetic glucocorticoid dexamethasone, which suppresses ACTH secretion via negative feedback, clinicians can assess whether the HPA axis retains normal feedback sensitivity.

Physiological Principle

In healthy individuals, exogenous glucocorticoids suppress the HPA axis: dexamethasone binds to glucocorticoid receptors in the hypothalamus and pituitary, reducing CRH and ACTH release, which in turn suppresses adrenal cortisol production. The next morning, serum cortisol levels should be very low.

In Cushing's syndrome, regardless of the underlying cause, this normal suppression is impaired. Cortisol production continues despite the presence of exogenous dexamethasone.

The Overnight 1 mg Dexamethasone Suppression Test (ONDST)

The overnight 1 mg DST is the most widely used initial screening test for Cushing's syndrome in many clinical settings:

Protocol:

1. Patient takes 1 mg of dexamethasone orally at 11:00 PM
2. Serum cortisol is drawn at 8:00–9:00 AM the following morning
3. No special dietary preparation is required, though dexamethasone should be taken with food to minimize gastric irritation

Interpretation:

• Suppression (normal): Morning cortisol ≤ 1.8 μg/dL (50 nmol/L) — Cushing's syndrome is effectively excluded
• Non-suppression (abnormal): Morning cortisol > 1.8 μg/dL — requires further evaluation

The 1.8 μg/dL (50 nmol/L) cutoff has high sensitivity (~95%) for Cushing's syndrome at the cost of reduced specificity (approximately 80%), meaning false positives are not uncommon.

Causes of False-Positive ONDST Results (Pseudo-Cushing's)

A number of conditions and substances can cause failure to suppress cortisol after dexamethasone, mimicking Cushing's syndrome:

• Depression and anxiety disorders: HPA axis hyperactivity in major depressive disorder can blunt DST suppression
• Alcoholism: Alcohol-related cortisol excess is a classic cause of pseudo-Cushing's
• Obesity and metabolic syndrome: Mild HPA axis overactivity
• Medications that accelerate dexamethasone metabolism: Rifampicin, carbamazepine, phenytoin, phenobarbital — these induce CYP3A4, lowering dexamethasone levels and allowing cortisol to remain unsuppressed
• Estrogen therapy and pregnancy: Elevate CBG and total cortisol
• Renal and liver disease: Affect dexamethasone and cortisol metabolism
• Acute illness or hospitalization: Stress-related cortisol elevation

The Two-Day Low-Dose Dexamethasone Suppression Test

For greater specificity, some protocols use the two-day LDDST:

Protocol:

1. Administer 0.5 mg of dexamethasone every 6 hours for 48 hours (total: 8 doses, 4 mg total)
2. Collect serum cortisol 6 hours after the last dose
3. Alternatively, collect 24-hour urine cortisol on the second day of dexamethasone

Interpretation:

• Suppression: Serum cortisol ≤ 1.8 μg/dL or UFC ≤ 10 μg/24h — argues against Cushing's
• Non-suppression: Consistent with Cushing's syndrome, requiring further workup

The two-day LDDST offers somewhat improved specificity compared to the overnight test but is more cumbersome and rarely changes clinical management when the overnight test is combined with other screening tests (UFC, LNSC).

High-Dose DST: Differentiating Cushing's Disease from Ectopic ACTH

Once Cushing's syndrome has been confirmed, the high-dose DST (8 mg overnight or two-day 2 mg q6h) is sometimes used to distinguish pituitary Cushing's disease (where some suppression may occur) from ectopic ACTH syndrome (where suppression typically does not occur). However, this test has largely been replaced by inferior petrosal sinus sampling (IPSS) and pituitary MRI in most modern Cushing's syndrome workup algorithms.

Cushing's Syndrome Cortisol Test: Diagnostic Protocols

Cushing's syndrome cortisol test selection and interpretation represent one of the most nuanced areas of clinical endocrinology. Cushing's syndrome — defined as pathological, sustained cortisol excess — requires a systematic, multi-step diagnostic approach that distinguishes it from pseudo-Cushing's states and then localizes the source of excess cortisol production.

Clinical Presentation: Who Should Be Tested?

Testing for Cushing's syndrome is indicated in patients with:

• Classic features: Central (truncal) obesity with peripheral wasting, violaceous (purple) striae >1 cm wide, easy bruising, proximal muscle weakness, moon facies, dorsocervical fat pad ("buffalo hump"), supraclavicular fat pads
• Associated metabolic features: Hypertension refractory to standard treatment, type 2 diabetes, osteoporosis (especially in young adults), recurrent opportunistic infections
• Incidentally discovered adrenal adenoma (adrenal incidentaloma) — up to 20% may have subclinical cortisol excess
• Children: Growth deceleration with increasing weight gain (a cardinal sign in pediatric Cushing's)
• Multiple endocrine neoplasia (MEN) type 1 or related syndromes

Step 1: First-Line Screening Tests (Any of Three Recommended)

Current Endocrine Society guidelines recommend using at least one of three first-line tests for initial screening:

1. Late-Night Salivary Cortisol (LNSC): Two separate midnight collections. Sensitivity 100%, specificity >96% at a cutoff of >6.1 nM — the most sensitive of the three options for detecting early Cushing's
2. 24-Hour Urinary Free Cortisol (UFC): Preferably two collections. Best performed with LC-MS/MS for specificity.
3. Overnight 1 mg Dexamethasone Suppression Test (ONDST): A morning cortisol >1.8 μg/dL after 1 mg dexamethasone at midnight is abnormal.

In cases with low pretest probability, a normal result on one test may be sufficient to exclude Cushing's. In higher pretest probability cases, or when a result is equivocal, testing with a second modality is recommended before concluding that results are abnormal.

Step 2: Confirming Hypercortisolism

If one screening test is positive:

• Repeat the same test, or
• Perform one of the other two first-line tests

If two tests are abnormal, the diagnosis of hypercortisolism is established and further evaluation proceeds to localization.

Step 3: Differentiating ACTH-Dependent from ACTH-Independent Cushing's

Once hypercortisolism is confirmed, the cause must be determined:

Measure plasma ACTH:

• ACTH suppressed (<10 pg/mL): ACTH-independent (adrenal source) → Adrenal CT scan
• ACTH elevated or normal (>15 pg/mL): ACTH-dependent → Pituitary disease (Cushing's disease) or ectopic ACTH
• ACTH borderline (10–15 pg/mL): Repeat measurement or proceed with CRH stimulation

Step 4: Localizing ACTH-Dependent Cushing's

For ACTH-dependent cases:

1. Pituitary MRI: Can identify a pituitary adenoma in 60–70% of cases (microadenomas <6mm may be missed)
2. CRH stimulation test: Cushing's disease typically shows an exaggerated ACTH and cortisol response; ectopic ACTH syndrome typically does not respond
3. Bilateral inferior petrosal sinus sampling (IPSS): The gold standard for distinguishing pituitary from ectopic ACTH. An IPSS:peripheral ACTH ratio >2 basally or >3 post-CRH confirms pituitary source.

Cyclical Cushing's Syndrome: A Diagnostic Challenge

In cyclical Cushing's syndrome, cortisol excess waxes and wanes over days to weeks. Patients may have normal test results during "off" cycles. Clinicians should:

• Perform repeated testing over time, particularly when the patient is symptomatic
• Consider maintaining a cortisol diary with serial late-night salivary cortisol measurements
• Use UFC over multiple collection periods to capture peak secretion

★★★★★ 4.8 · 1,247 reviews

See Why Athletes And Executives Take It Daily.

Adaptogen-based formula, third-party tested, made in the USA. Cancel subscription anytime.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Clinical Cortisol Evaluation: Interpreting Results

Clinical cortisol evaluation is not simply about comparing a number to a reference range. Meaningful interpretation requires integration of the clinical context, timing of collection, specimen type, assay methodology, and patient-specific variables. This section provides a practical framework for clinicians interpreting cortisol results across different scenarios.

Framework for Clinical Cortisol Interpretation

When reviewing a cortisol result, ask the following questions systematically:

1. What was the clinical question?

• Suspected deficiency (adrenal insufficiency)?
• Suspected excess (Cushing's syndrome)?
• Monitoring of known condition or replacement therapy?

2. What specimen was used and when was it collected?

• Morning serum cortisol vs. late-night salivary cortisol have fundamentally different reference ranges and clinical uses
• Was the sample collected at the optimal time for the diagnostic question?

3. Was this a dynamic (stimulation/suppression) test or a basal measurement?

• Dynamic test results must be interpreted against the expected response pattern, not simply a static reference range

4. What analytical method was used?

• Immunoassay results may be affected by cross-reactivity; LC-MS/MS results are more specific
• Is the result concordant across methods if multiple tests were performed?

5. Are there factors that could confound the result?

• CBG abnormalities, medications, illness, stress at the time of collection

Interpreting a Low Morning Serum Cortisol

A morning cortisol <3 μg/dL (<83 nmol/L) drawn at 8:00–9:00 AM is highly suggestive of adrenal insufficiency and may not require further confirmatory testing in the appropriate clinical context (with appropriate symptoms and risk factors).

A morning cortisol between 3 and 18 μg/dL is indeterminate and warrants ACTH stimulation testing.

A morning cortisol >18 μg/dL effectively excludes clinically significant adrenal insufficiency in most scenarios.

Interpreting a High Cortisol Result

Cortisol elevation must be interpreted carefully:

| Degree of Elevation | Possible Interpretation | |---|---| | Mildly elevated (1–2x ULN) | Pseudo-Cushing's, physical or emotional stress, medications, poor timing of sample | | Moderately elevated (2–4x ULN) | Stronger suspicion for Cushing's; requires dynamic testing | | Markedly elevated (>4x ULN on UFC) | Strong evidence for pathological hypercortisolism; initiate full workup |

Interpreting Dynamic Test Results

ACTH Stimulation:

• Peak cortisol ≥18 μg/dL: Normal adrenal reserve — adrenal insufficiency is unlikely
• Peak cortisol <18 μg/dL: Adrenal insufficiency confirmed — determine primary vs. secondary with ACTH level

1 mg Overnight DST:

• Cortisol ≤1.8 μg/dL: Suppressed — Cushing's syndrome effectively excluded
• Cortisol 1.8–5 μg/dL: Indeterminate — proceed with additional testing (UFC, LNSC)
• Cortisol >5 μg/dL: Strong evidence for pathological cortisol excess

Documentation and Communication of Results

When documenting cortisol results, clinicians should record:

• The exact time and date of sample collection
• The test type and specimen (e.g., "serum cortisol, 8:15 AM" vs. "late-night salivary cortisol, 11:30 PM")
• The assay platform and methodology if known
• Any medications, supplements, or clinical circumstances relevant to interpretation
• The clinical interpretation in context — not just whether the result is above or below the reference range

Total Cortisol vs. Free Cortisol: Which Is Clinically Relevant?

The distinction between total cortisol and free cortisol is one of the most important — and most frequently overlooked — concepts in cortisol clinical testing. The clinical relevance of this distinction grows when patients have abnormal protein levels, when binding proteins are altered by physiological or pathological states, or when precision matters for monitoring therapy.

Understanding the Difference

As previously discussed, cortisol in the blood exists in two main forms:

• Total cortisol = protein-bound cortisol (mostly CBG-bound) + free cortisol
• Free cortisol = the biologically active, unbound fraction (~5–10% of total)

Standard serum cortisol immunoassays measure total cortisol. The assumption embedded in clinical reference ranges is that CBG levels are normal and that free cortisol therefore represents a predictable proportion of total cortisol. When this assumption breaks down, total cortisol can mislead.

When Total Cortisol Misleads

Elevated CBG states (falsely high total cortisol):

• Pregnancy (estrogen increases hepatic CBG synthesis by 2–3x)
• Estrogen therapy (oral contraceptives, hormone replacement therapy)
• Familial CBG excess

In these patients, total cortisol may appear elevated, but free cortisol — and hence physiological cortisol effect — is entirely normal. A diagnosis of Cushing's syndrome based solely on a high morning serum cortisol in a pregnant patient or one using oral contraceptives is incorrect.

Reduced CBG states (falsely low total cortisol):

• Nephrotic syndrome (urinary loss of CBG and albumin)
• Liver cirrhosis and liver failure (reduced hepatic synthesis of CBG)
• Critical illness (acute phase response sharply reduces CBG levels)
• Hypothyroidism
• Familial CBG deficiency

In critical illness specifically, a total cortisol that appears "low" may actually be associated with a normal or even elevated free cortisol, because the dramatically reduced CBG means that proportionally more cortisol is circulating freely. Studies have shown that in ICU patients, free cortisol measured by equilibrium dialysis often correlates better with illness severity and adrenal function than total cortisol.

Methods for Measuring Free Cortisol

1. Equilibrium dialysis: The gold standard laboratory method. Serum is dialyzed against a buffer at physiological temperature; free cortisol in the dialysate is then measured. Technically demanding and not widely available in routine clinical labs.

1. Calculated free cortisol: Using mathematical models based on total cortisol, measured CBG, and albumin concentrations. The Coolens equation and its modifications offer reasonable estimates. Increasingly used in research and specialist endocrinology centers.

1. Salivary cortisol: The most practical clinical proxy for free cortisol. Because only free cortisol enters the salivary glands, salivary cortisol directly reflects free cortisol levels without the technical complexity of equilibrium dialysis.

1. Urinary free cortisol: As discussed, UFC also reflects free cortisol (filtered by the kidney) and is useful for quantifying free cortisol exposure over 24 hours.

Free Cortisol Measurement in Practice

For most routine clinical scenarios, total serum cortisol is adequate and clinically reliable. Measuring free cortisol (or using salivary cortisol as a proxy) should be prioritized in:

• Patients on oral contraceptives or estrogen therapy undergoing Cushing's syndrome evaluation
• Pregnant patients
• Critically ill patients where the clinical picture does not fit the total cortisol result
• Patients with nephrotic syndrome or hepatic failure
• Monitoring hydrocortisone replacement when CBG levels may be abnormal

Cortisol Testing Methods Clinical Comparison: Immunoassay vs. LC-MS/MS

The analytical method used to measure cortisol in clinical samples is not merely a laboratory technicality — it has direct implications for diagnostic accuracy, test interpretation, and patient outcomes. Understanding the difference between cortisol testing methods clinical labs use helps clinicians choose the right test and interpret results correctly.

Immunoassay: The Workhorse of Routine Testing

Immunoassays are the most widely used analytical platform for cortisol measurement in routine clinical laboratories worldwide. They rely on the competitive binding of cortisol to a specific antibody, with signal generation proportional to the amount of cortisol in the sample.

Types of immunoassay used for cortisol:

• Radioimmunoassay (RIA): The original method; now largely replaced in most labs
• Enzyme-linked immunosorbent assay (ELISA): Used in some research and specialized labs
• Automated chemiluminescent immunoassay (CLIA): The dominant method in modern automated clinical analyzers (e.g., Abbott ARCHITECT, Siemens ADVIA Centaur, Roche Cobas)

Advantages:

• High throughput; results available within hours
• Widely available in most hospital and reference labs
• Cost-effective
• Well-validated for serum total cortisol
• Automated and standardized within individual platforms

Key limitation: Cross-reactivity and Inter-assay Variability

Common automated immunoassays suffer significant cross-reactivity with steroidal analogues and exhibit significant inter-assay variability, which can compromise diagnostic accuracy. Specifically:

• Synthetic glucocorticoids (prednisolone, prednisone, methylprednisolone): Can cross-react with cortisol antibodies, causing falsely elevated cortisol readings in patients taking these medications
• Cortisone: The major endogenous metabolite of cortisol, present at high concentrations in saliva and urine, can cross-react in salivary and urinary immunoassays
• Other steroid hormones: Deoxycorticosterone, corticosterone, and some exogenous steroids may show variable cross-reactivity
• Inter-assay variability: The same patient sample may yield meaningfully different cortisol values when run on different immunoassay platforms — a problem that complicates interpretation when patients move between hospitals or when reference ranges are applied from different platforms

This variability is clinically significant. A cortisol result of 480 nmol/L on one platform might be classified as "borderline low" (normal reference range up to 500 nmol/L) while the same sample on a different platform might measure as 520 nmol/L and be classified as normal — potentially altering clinical management.

Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS)

LC-MS/MS is now considered the method of choice for salivary cortisol and is regarded as the gold standard for free cortisol measurement across clinical and research applications.

How it works: Cortisol (and other steroids) are separated by liquid chromatography based on their physical properties, then ionized and detected by mass spectrometry based on their precise molecular mass-to-charge ratio. This double-stage separation and identification provides extraordinary specificity.

Advantages:

• Unmatched specificity: Can distinguish cortisol from cortisone, corticosterone, and most synthetic steroids by molecular weight
• Superior sensitivity: Capable of detecting cortisol at very low concentrations (important for salivary and urinary samples at night-time nadir)
• Simultaneous multi-steroid profiling: A single LC-MS/MS run can measure cortisol, cortisone, DHEAS, testosterone, aldosterone, and other steroids simultaneously — increasingly valuable for adrenal workup
• Reduced inter-assay variability: More consistent results across samples and laboratories using standardized reference materials
• Eliminates most cross-reactivity issues: Critical for monitoring patients on synthetic glucocorticoids or for salivary cortisol where cortisone contamination is a concern

Limitations:

• Higher capital cost of instrumentation
• Requires specialized technical expertise
• Longer turnaround time compared to automated immunoassay
• Not universally available in smaller clinical laboratories (though access through reference labs is increasing)
• Requires careful sample preparation and handling

Clinical Recommendation: When to Request LC-MS/MS

Clinicians should specify or request LC-MS/MS methodology in the following situations:

1. Salivary cortisol for Cushing's syndrome screening: Immunoassay cross-reactivity with cortisone in saliva significantly reduces specificity; LC-MS/MS is definitively preferred
2. Patients on synthetic glucocorticoids who need concurrent cortisol monitoring
3. Equivocal or discordant immunoassay results — particularly when clinical features strongly suggest pathology but assay results are borderline
4. Free cortisol measurement in patients with known CBG abnormalities
5. Pediatric testing where sample volumes may be small and sensitivity at low concentrations is important
6. Steroid profiling in adrenal incidentaloma evaluation or suspected inborn errors of steroidogenesis

Emerging Methods: Biosensors and Point-of-Care Testing

Recent technical advancements in cortisol biosensors and integrated ambient ionization–miniature mass spectrometry systems show promise for point-of-care (POC) cortisol monitoring. These technologies aim to bring cortisol testing outside the clinical laboratory — to bedside, clinic, or even the patient's home — using electrochemical, optical, or miniaturized mass spectrometric detection.

However, these platforms remain in development and are not yet standardized for routine clinical use. Current biosensor technology faces challenges including sensitivity at low concentrations, matrix interference from complex biological samples, and the need for regulatory validation before clinical deployment.

Factors That Affect Cortisol Test Results

Accurate interpretation of any cortisol test requires awareness of the many physiological, pharmacological, and technical factors that can influence cortisol levels or the test result itself. Understanding these variables helps clinicians identify false positives and false negatives and counsel patients appropriately before testing.

Physiological and Behavioral Factors

1. Circadian Rhythm and Timing of Testing As discussed extensively, cortisol peaks in the morning and troughs at night. Failure to collect samples at the correct time is one of the most common sources of clinically misleading results.

2. Stress at the Time of Sampling Physical or psychological stress acutely elevates cortisol via CRH-ACTH-adrenal activation. Causes of elevated cortisol at the time of testing include:

• Acute illness or hospitalization
• Venipuncture anxiety (particularly in children)
• Physical pain
• Anxiety disorders
• Pre-procedural stress

Salivary cortisol at midnight can be falsely elevated if the patient is anxious, in pain, or has been disturbed from sleep to collect the sample.

3. Sleep Deprivation and Shift Work Insufficient or disrupted sleep elevates cortisol, especially evening and nighttime levels. Night-shift workers and others with inverted sleep-wake cycles will have inverted cortisol rhythms. Late-night salivary cortisol cutoffs may not apply if the "midnight" collection does not correspond to the patient's physiological nadir.

4. Exercise Vigorous exercise significantly elevates cortisol. Patients should be instructed to avoid strenuous exercise for at least 12 hours before testing, particularly for urine and blood collections.

5. Alcohol and Smoking Chronic alcoholism and binge drinking are classic causes of pseudo-Cushing's syndrome, with elevated cortisol and failure to suppress on DST. Tobacco smoking can also mildly elevate cortisol.

6. Nutritional Status Prolonged fasting, anorexia nervosa, and extreme caloric restriction can activate the HPA axis and elevate cortisol. Conversely, the postprandial period can cause transient cortisol fluctuations.

7. Body Weight Obesity is independently associated with mild HPA axis overactivity and can cause borderline elevations in UFC and modest failure to suppress on DST, contributing to the pseudo-Cushing's differential.

Medications That Affect Cortisol Results

Medications that INCREASE measured cortisol or impair DST suppression:

• CYP3A4 inducers (rifampicin, phenytoin, carbamazepine, phenobarbital, St. John's Wort): Accelerate dexamethasone metabolism, reducing its suppressive effect → false-positive DST
• Estrogen-containing medications (OCPs, HRT): Increase CBG → elevated total cortisol
• Mitotane: Increases CBG
• Spironolactone: Cross-reacts with some cortisol immunoassays

Medications that DECREASE measured cortisol:

• Exogenous glucocorticoids (prednisone, prednisolone, hydrocortisone, dexamethasone): Suppress the HPA axis → lower endogenous cortisol. Note: Dexamethasone does not cross-react in most cortisol immunoassays, which is why it is used in suppression testing. However, prednisolone and hydrocortisone DO cross-react and can falsely elevate or falsely suppress measured endogenous cortisol, depending on the scenario.
• Megestrol acetate, medroxyprogesterone: Glucocorticoid activity that suppresses HPA axis
• Ketoconazole, fluconazole, etomidate: Inhibit cortisol synthesis → support healthy cortisol levels
• Mitotane (adrenolytic): Markedly reduces adrenal cortisol production

Medications with complex or variable effects:

• Antidepressants: SSRIs and tricyclics can normalize elevated HPA axis activity in depressed patients, potentially converting a false-positive DST to normal
• Opioids: Suppress the HPA axis; chronic opioid therapy can cause secondary adrenal insufficiency

Medical Conditions Affecting Cortisol Test Interpretation

| Condition | Effect on Cortisol Testing | |---|---| | Pregnancy | Elevated total cortisol (high CBG); use salivary cortisol for evaluation | | Liver disease/cirrhosis | Low CBG → low total cortisol; may falsely suggest adrenal insufficiency | | Nephrotic syndrome | Low CBG and albumin → low total cortisol | | Critical illness | Low CBG; altered cortisol metabolism; total cortisol unreliable | | Hypothyroidism | Slowed cortisol metabolism; may elevate serum cortisol modestly | | Hyperthyroidism | Accelerated cortisol clearance | | Renal failure | Impaired UFC collection; altered cortisol metabolism | | Depression | HPA axis hyperactivity; can cause false-positive DST | | Anorexia nervosa | Elevated cortisol; pseudo-Cushing's pattern |

At-Home Cortisol Tests vs. Laboratory Testing: An Honest Comparison

The proliferation of direct-to-consumer (DTC) cortisol testing products has created new opportunities for patient empowerment but also new risks of misinterpretation and inappropriate self-management. Understanding the true capabilities and limitations of at-home testing compared to clinical laboratory testing is essential for both clinicians and patients.

What At-Home Cortisol Tests Typically Offer

At-home cortisol test kits — available through companies such as Everlywell, LetsGetChecked, and various wellness brands — typically involve:

• Salivary cortisol collection: Usually 4 collections across the day (morning waking, mid-morning, afternoon, and evening) to create a diurnal cortisol curve
• Immunoassay-based analysis: Samples are mailed to a partner laboratory for analysis
• Online results with general interpretation: Results are presented visually with guidance categorizing levels as "normal," "elevated," or "low"
• Cost: Typically ranges from $75 to $200 depending on the number of time points and whether additional markers are included

Strengths of At-Home Testing

• Convenience: Collection in the patient's own environment without clinical visit
• Captures diurnal pattern: Multiple time-point collection gives a more complete picture than a single morning blood draw
• Non-invasive: Salivary collection avoids venipuncture
• Accessibility: Enables testing for individuals without easy access to specialist healthcare
• Potential for longitudinal monitoring: Some programs allow repeated testing over time to track trends

Significant Limitations of At-Home Cortisol Testing

1. Analytical Methodology Most DTC cortisol tests use immunoassay platforms, not LC-MS/MS. As discussed, immunoassays are subject to cross-reactivity with cortisone and other steroids, potentially producing inaccurate results — particularly for salivary samples.

2. Lack of Clinical Contextualization A DTC result cannot substitute for a clinical diagnosis. A mildly elevated evening cortisol in an at-home test might reflect:

• Cushing's syndrome
• Chronic psychological stress with HPA hyperactivity
• Sleep deprivation the night before collection
• Delayed cortisol nadir in an evening-chronotype individual
• Sample contamination from food, drink, or tooth brushing

Without clinical history, physical examination, and integration with other findings, this result cannot be appropriately interpreted.

3. No Dynamic Testing At-home tests measure basal cortisol only. They cannot perform ACTH stimulation tests or dexamethasone suppression tests — the most clinically definitive tests for adrenal insufficiency and Cushing's syndrome, respectively.

4. Quality Control and Regulatory Oversight Unlike CLIA-certified clinical laboratories, the quality control standards, reference ranges, and reporting practices of DTC testing companies are not uniform and may not meet the same standards as institutional laboratory testing.

5. Risk of Inappropriate Action or Reassurance Patients who receive an "elevated" at-home cortisol result may experience significant anxiety and pursue unnecessary follow-up, or conversely, may delay seeking medical attention based on a "normal" result when clinical features of adrenal pathology are present.

Clinical Recommendation

At-home cortisol tests can serve as a useful initial awareness tool or as a way to collect multiple time-point samples that would be logistically difficult in a clinical setting. However, they should not be used as the sole basis for clinical decision-making and should not replace formal clinical cortisol evaluation when pathology is suspected.

Any patient with symptoms suggestive of adrenal disease — significant fatigue, unexplained weight changes, blood pressure abnormalities, skin changes, or metabolic disturbance — should be referred for formal clinical laboratory testing with appropriate methodology and medical interpretation.

Normal vs. Abnormal Cortisol Levels: A Clinical Reference

Interpreting whether a cortisol level is clinically normal or abnormal requires integration of specimen type, time of collection, clinical context, and assay-specific reference ranges. The following section provides a practical reference framework.

Serum Cortisol Reference Ranges

| Time of Collection | Normal Range (Approximate) | Notes | |---|---|---| | 8:00–9:00 AM (morning) | 50–163 ng/mL (~138–450 nmol/L; ~5–16 μg/dL) | Standard clinical reference; reflects morning peak | | Afternoon (4:00 PM) | Approximately 40–60% of morning value | Varies widely; not a standardized clinical threshold | | Late evening/midnight | <50 nmol/L (<~4 μg/dL) | Should reflect near-nadir in healthy individuals |

Note: The normal serum cortisol range of approximately 50–163 ng/mL reflects standard clinical laboratory reference values. These ranges vary between laboratories and assay platforms and should always be compared against the specific lab's reference interval.

Salivary Cortisol Reference Ranges

| Time of Collection | Normal Range (Approximate) | |---|---| | Morning (within 30 min of waking) | Variable; typically 10–30 ng/mL (reflects peak of cortisol awakening response) | | Reference midpoint | ~5.27 ng/mL (general reference; time-dependent) | | Late-night (11:00 PM–midnight) | <2.2 ng/mL (<6.1 nM); values above this threshold are considered abnormal in validated Cushing's screening protocols |

24-Hour Urinary Free Cortisol Reference Ranges

| Method | Normal Range | |---|---| | Immunoassay | 10–100 μg/24 hours (27.6–276 nmol/24 hours) | | LC-MS/MS | Typically lower than immunoassay; consult laboratory-specific reference | | Pediatric | Age-adjusted; typically lower |

Values >300 μg/24 hours (>830 nmol/24 hours) are considered definitively elevated and strongly suggestive of pathological hypercortisolism.

ACTH Stimulation Test Thresholds

| Result | Interpretation | |---|---| | Peak cortisol ≥18 μg/dL (500 nmol/L) | Normal adrenal reserve | | Peak cortisol <18 μg/dL | Adrenal insufficiency (primary or secondary) |

DST Interpretation Thresholds

| Post-Dexamethasone Cortisol | Interpretation | |---|---| | ≤1.8 μg/dL (50 nmol/L) | Normal suppression; Cushing's syndrome excluded | | >1.8 μg/dL to 5 μg/dL | Indeterminate; further testing required | | >5 μg/dL (138 nmol/L) | Abnormal; strong suspicion for Cushing's syndrome |

Interpreting Abnormally Low Cortisol

When is a low cortisol clinically significant?

• Morning serum cortisol <3 μg/dL (<83 nmol/L): Strongly suggestive of adrenal insufficiency in the appropriate clinical context
• Morning serum cortisol 3–18 μg/dL: Indeterminate; ACTH stimulation testing required
• Peak cortisol on ACTH stimulation <18 μg/dL: Confirms adrenal insufficiency

Common causes of low cortisol:

• Primary adrenal insufficiency (Addison's disease): Autoimmune destruction of adrenal cortex (most common in high-income countries); also tuberculosis, adrenal hemorrhage/infarction, metastatic malignancy
• Secondary adrenal insufficiency: Pituitary insufficiency (pituitary tumor, surgery, radiation, apoplexy, traumatic brain injury)
• Tertiary adrenal insufficiency: Hypothalamic disease; most commonly exogenous glucocorticoid suppression (abrupt withdrawal of chronic steroid therapy)
• Congenital adrenal hyperplasia (CAH): Enzyme deficiencies reducing cortisol synthesis (elevated ACTH, elevated precursors)

Interpreting Abnormally High Cortisol

Common causes of high cortisol:

• Cushing's syndrome: Pituitary adenoma (Cushing's disease, ~70%), adrenal adenoma/carcinoma (~20%), ectopic ACTH secretion (~10%)
• Pseudo-Cushing's states: Depression, alcoholism, obesity, poorly controlled diabetes, physical illness
• Exogenous glucocorticoids: If immunoassay cross-reacts (prednisolone, hydrocortisone)
• CBG elevation: Pregnancy, OCP use — total cortisol elevated but free cortisol normal
• Acute physiological stress: Hospitalization, surgery, trauma, sepsis

★★★★★ 4.8 · 1,247 reviews

Ready To Try Adaptogen-Based Cortisol Support?

Third-party tested. 60-day guarantee. Free shipping over $40. Ships in 24 hours.

Shop Cortisol Drops →

✓ 60-day guarantee ✓ Free shipping $40+ ✓ Ships in 24hrs

Frequently Asked Questions

What is the best sample type for cortisol testing — blood, urine, or saliva?

There is no single "best" sample type; the optimal specimen depends entirely on the clinical question. Blood (serum) is best for morning cortisol screening (adrenal insufficiency, general endocrine evaluation) and dynamic testing (ACTH stimulation, DST). Saliva is the preferred specimen for late-night cortisol to screen for Cushing's syndrome, offering high sensitivity (100%) and specificity (>96%) with non-invasive collection. Urine (24-hour) quantifies total daily free cortisol output and is one of the three recommended first-line tests for Cushing's syndrome. For patients where CBG levels may be distorted (pregnancy, critical illness), salivary or urine free cortisol is preferred over serum total cortisol.

How accurate are at-home cortisol tests compared to lab tests?

At-home cortisol tests using immunoassay methodology are generally less analytically reliable than clinical laboratory testing, particularly for salivary samples where cortisone cross-reactivity is a known confounder. They can provide useful general information about diurnal cortisol patterns but should not be used as the basis for diagnosing or excluding adrenal pathology. For clinical decision-making, formal laboratory testing — ideally with LC-MS/MS methodology where available — is strongly preferred. Patients who are concerned about their cortisol levels should seek a clinical evaluation rather than relying solely on DTC test results.

Why do cortisol levels vary throughout the day, and when should I test?

Cortisol follows a tightly regulated circadian rhythm driven by the hypothalamus. Levels are highest in the morning (peaking approximately 30–45 minutes after waking, typically between 6:00 and 9:00 AM) and fall progressively throughout the day to a nadir in the late evening (around midnight). This rhythm is essential for normal metabolic function and sleep-wake regulation. The diagnostic value of cortisol testing depends heavily on when the sample is collected: morning cortisol tests assess adrenal reserve and screen for deficiency; late-night cortisol tests (particularly salivary) exploit the normal nadir to detect cortisol excess. Always ensure samples are collected at the clinically appropriate time for the question being answered.

Can stress, medications, or sleep affect my cortisol test results?

Yes — significantly. Physical or emotional stress (including anxiety, pain, illness, or even the stress of venipuncture itself) can acutely elevate cortisol at the time of testing, creating false impressions of cortisol excess. Sleep deprivation elevates evening cortisol, potentially causing a false-positive late-night salivary cortisol result. Many medications affect cortisol results: drugs that speed dexamethasone metabolism (rifampicin, phenytoin, carbamazepine) cause false-positive DST results; estrogens raise CBG and total cortisol; exogenous glucocorticoids suppress endogenous production. Patients should always disclose all medications and relevant health circumstances before cortisol testing, and clinicians should account for these factors in interpretation.

What is the difference between total cortisol and free cortisol, and which is clinically relevant?

Total cortisol measures all circulating cortisol — both protein-bound (~90–95%) and free (~5–10%). Free cortisol is the biologically active fraction that enters cells and exerts physiological effects. Standard blood tests measure total cortisol, which is clinically reliable when binding protein (CBG) levels are normal. However, in conditions that alter CBG — pregnancy, oral contraceptive use, liver disease, nephrotic syndrome, critical illness — total cortisol can be misleadingly high or low. In these situations, free cortisol (measured by salivary cortisol, equilibrium dialysis, or calculated from total cortisol and CBG) provides a more accurate picture of actual cortisol activity. For most routine clinical scenarios, total cortisol is adequate; however, clinicians should specifically consider free cortisol measurement when CBG distortion is suspected.

How is cortisol testing used to diagnose Addison's disease or Cushing's syndrome?

Addison's disease (primary adrenal insufficiency) is suspected when morning serum cortisol is low (<3 μg/dL is highly suggestive; 3–18 μg/dL is indeterminate) and confirmed by an inadequate response on the ACTH stimulation test (peak cortisol <18 μg/dL). A simultaneously elevated plasma ACTH distinguishes primary from secondary adrenal insufficiency.

Cushing's syndrome is screened using one or more of three first-line tests: late-night salivary cortisol (the most sensitive, at 100%), 24-hour urinary free cortisol, or the overnight 1 mg dexamethasone suppression test. Two abnormal results on first-line testing confirm hypercortisolism, after which the source is localized using plasma ACTH, pituitary MRI, CRH stimulation testing, and where necessary, inferior petrosal sinus sampling.

What do normal vs. abnormal cortisol levels mean?

A "normal" cortisol level indicates that cortisol production and regulation are functioning appropriately for the time of day and clinical circumstances. "Abnormal" results — whether high or low — indicate that further evaluation is needed. An abnormal result does not automatically mean disease is present; as discussed throughout this guide, many factors can produce false positives or false negatives. The meaning of a cortisol result must always be interpreted in the context of: the specimen type, timing of collection, the patient's clinical presentation, concurrent medications, and any dynamic testing performed. An endocrinologist's expertise is often valuable when cortisol results are abnormal or inconsistent.

Summary and Clinical Takeaways

Cortisol testing in clinical practice is a multidimensional discipline that requires careful integration of test selection, timing, specimen type, analytical methodology, and clinical context. The following key takeaways summarize the most important points from this guide:

Key Clinical Takeaways

1. Choose the right test for the right clinical question

• For suspected adrenal insufficiency: Start with a morning serum cortisol; confirm with ACTH stimulation test
• For suspected Cushing's syndrome: Use one or more first-line screening tests — late-night salivary cortisol, 24-hour UFC, or 1 mg overnight DST
• For monitoring hydrocortisone replacement: Salivary cortisol (free cortisol proxy) is increasingly preferred over serum total cortisol

2. Timing is non-negotiable The diurnal cortisol rhythm is the foundation of clinical interpretation. Morning samples assess adrenal reserve; late-night samples detect loss of normal suppression. An incorrectly timed sample can produce a result that is technically accurate but clinically misleading.

3. Know the limitations of immunoassay Standard automated immunoassays are the most common testing platform but are subject to cross-reactivity with steroidal analogues and significant inter-assay variability. For salivary cortisol and complex cases, LC-MS/MS is analytically superior and increasingly accessible through reference laboratories.

4. Free cortisol matters — especially in altered binding protein states Total serum cortisol can be misleading in pregnancy, oral contraceptive use, liver disease, nephrotic syndrome, and critical illness. In these scenarios, salivary cortisol or calculated free cortisol provides more clinically accurate information.

5. Late-night salivary cortisol is the most sensitive first-line test for Cushing's syndrome With 100% sensitivity and >96% specificity at a validated cutoff of >6.1 nM, LNSC outperforms UFC and DST for early detection — and has the added advantage of non-invasive, home-based collection.

6. Two abnormal results before acting The Endocrine Society recommends that at least two abnormal first-line tests be obtained before concluding that Cushing's syndrome is present, to reduce false positives from pseudo-Cushing's states and assay variability.

7. Dynamic testing is definitive where basal tests are indeterminate The ACTH stimulation test and dexamethasone suppression tests provide information about HPA axis function that cannot be obtained from basal cortisol measurements alone. When basal results are borderline, dynamic testing resolves clinical uncertainty.

8. Account for confounders before concluding pathology Medications (particularly CYP3A4 inducers and estrogens), stress, sleep disruption, alcohol use, and underlying conditions (depression, obesity, critical illness) all affect cortisol results. A systematic review of potential confounders should precede any definitive diagnostic conclusion.

9. The future of cortisol testing is moving toward greater precision and accessibility LC-MS/MS is rapidly becoming the new standard for cortisol measurement, especially in academic and specialist centers. Point-of-care cortisol biosensors are in development, with potential for future real-time monitoring in clinical and home settings — though these require further validation before routine clinical adoption.

10. Always interpret cortisol results in clinical context A number that falls outside a reference range is a prompt for clinical thinking — not an automatic diagnosis. The history, physical examination, medication review, and additional dynamic testing all contribute to the full picture of clinical cortisol evaluation.

When to Refer to an Endocrinologist

Primary care clinicians should consider referral to an endocrinologist when:

• Morning cortisol is consistently low or borderline and/or the ACTH stimulation test is abnormal
• Two first-line screening tests for Cushing's syndrome are positive
• The clinical picture and laboratory results are discordant
• Complex confounders make interpretation uncertain
• Dynamic testing (CRH stimulation, IPSS) is required for localization
• Adrenal imaging reveals an incidentaloma requiring hormonal evaluation

This guide reflects clinical evidence and guidelines available up to 2023. For the most current clinical practice guidelines on cortisol testing, readers are encouraged to consult the Endocrine Society Clinical Practice Guidelines, European Society of Endocrinology (ESE) guidelines on adrenal insufficiency and Cushing's syndrome, and recent publications on PubMed, Scopus, or Google Scholar — particularly for emerging 2024–2026 research on LC-MS/MS validation, cortisol biosensors, and point-of-care monitoring technologies, which may further refine current practice recommendations.

References and Further Reading

1. Cleveland Clinic. (n.d.). Cortisol Test. https://my.clevelandclinic.org/health/diagnostics/22417-cortisol-test
2. MedlinePlus. (2017). Cortisol Test. U.S. National Library of Medicine. https://medlineplus.gov/lab-tests/cortisol-test/
3. Healthline. (n.d.). Cortisol Tests: Everything You Need to Know. https://www.healthline.com/health/cortisol-tests
4. Perogamvros, I., et al. (2016). Measuring cortisol in serum, urine and saliva: are our assays good enough? Annals of Clinical Biochemistry, 53(2), 177–193.
5. Raff, H., & Findling, J.W. (2003). A physiologic approach to diagnosis of the Cushing syndrome. Annals of Internal Medicine, 138(12), 980–991.
6. Nieman, L.K., et al. (2008). The diagnosis of Cushing's syndrome: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 93(5), 1526–1540.
7. Papanicolaou, D.A., et al. (1998). A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. Journal of Clinical Endocrinology & Metabolism, 83(4), 1163–1167.
8. Mohr, M., et al. (2023). Cortisol detection for connected health applications: A systematic review. Biosensors and Bioelectronics, 221, 114895.

Disclaimer: This blog post is intended for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis, treatment, and management of any medical condition.